Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: NewCardio, Inc.

Market Cap 862K 751K 696K 652K 1.22M 81.32M 1.23M 8.26M 3.2M 40.03M 3.24M 3.17M 139M P/E 2009
-1.65x
P/E 2010 -2.11x
Enterprise Value 3.28M 2.86M 2.65M 2.48M 4.65M 309M 4.67M 31.39M 12.17M 152M 12.3M 12.04M 528M EV / Sales 2009
-
EV / Sales 2010 108,128,357x
Free-Float
75.73%
Yield 2009 *
-
Yield 2010 -
Change 5-day change 1-year change 3-year change Capi.($)
-2.50%+62.50% - - 40
+0.63%-1.01%+18.35%-13.53% 173B
+1.14%-1.04%-20.16%+23.51% 144B
-0.33%-1.63%-8.88%-26.73% 125B
+0.76%-3.45%-55.32%-16.62% 67.32B
+0.78%+2.64%+18.09%-4.98% 50.3B
-0.58%-1.16%-25.42%-34.65% 43.8B
+2.20%-2.14%+9.99%+4.90% 35.89B
-0.44%-0.03%+4.74%+32.04% 34.9B
+0.72%-5.51%-14.33%-21.69% 28.02B
Average +0.24%-1.86%-8.11%-6.42% 78.04B
Weighted average by Cap. +0.54%-1.89%-6.63%-6.41%

Financials

2009 2010
Net sales - 0.26 0.22 0.21 0.19 0.36 24.29 0.37 2.47 0.96 11.95 0.97 0.95 41.51
Net income -9.59M -8.36M -7.74M -7.25M -13.6M -905M -13.68M -91.88M -35.61M -445M -36M -35.23M -1.55B -11.5M -10.02M -9.28M -8.69M -16.3M -1.08B -16.4M -110M -42.68M -534M -43.15M -42.23M -1.85B
Net Debt -1.41M -1.23M -1.14M -1.07M -2M -133M -2.01M -13.52M -5.24M -65.53M -5.3M -5.18M -228M 2.42M 2.11M 1.95M 1.83M 3.42M 228M 3.44M 23.14M 8.97M 112M 9.07M 8.87M 389M
Logo NewCardio, Inc.
NewCardio, Inc. (NewCardio), through its wholly owned subsidiary, NewCardio Technologies, Inc. (NewCardio Technologies), operates as a development-stage cardiac diagnostic technology provider focused on the research, development and commercialization of products and services for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of new drugs under development. The Company is focused on the development of a platform technology for its products, which will improve the diagnostic accuracy and value of the standard 12-lead electrocardiogram (ECG). The Company’s core technology platform provides real-time, three-dimensional (3D) analysis of the heart's electrical activity, as detected at the body surface by standard 12-lead ECG electrodes. ECG input signals are typically sampled at 500 hertz (500 times per second).
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!